latest news in companies
Restaurant Chain Il Fornaio Agrees to Pay Millions Over Workplace Abuse Claims
San Francisco, Monday, 19 October 2026.
Il Fornaio will pay $3 million after an investigation revealed widespread workplace harassment affecting over 100 women, triggering court-mandated human resources reforms across all locations.
Electric Commercial Trucks Double as Power Grid Backups in Oregon
Portland, Sunday, 18 October 2026.
Portland General Electric is utilizing heavy-duty electric vehicles as mobile energy storage, dispatching power back into the grid during peak demand to strengthen grid reliability and offset fleet emissions.
Artificial Intelligence Solves 25-Year Encryption Mystery Involving National Security Agency
San Francisco, Sunday, 18 October 2026.
Anthropic’s artificial intelligence model, Claude, has resolved a quarter-century-old cryptographic mystery in under 30 minutes. Researchers revealed that mysterious security numbers supplied by the National Security Agency in the late 1990s were generated using a basic computer clock program rather than a hidden backdoor. For decades, cryptographers harbored suspicions that these unexplained foundational numbers contained deliberate security weaknesses designed for government surveillance. The AI’s rapid analysis traced the exact system timestamps from 1997 and 1998 used to create the values, effectively ruling out intentional vulnerabilities and offering key reassurance for global digital security standards.
Microsoft Abandons Major British Artificial Intelligence Facility Over Power Grid Constraints
Essex, Sunday, 18 October 2026.
Microsoft’s withdrawal from a flagship British artificial intelligence data center due to severe power delays threatens infrastructure provider Nscale’s planned 35 billion dollar stock market debut.
Major Industrial Companies Hide Workplace Risks by Excluding Contractor Data
New York, Sunday, 18 October 2026.
A 2026 study reveals that most major industrial companies omit contractor injury data and working hours, concealing significant operational and compliance risks from investors and regulators.
Spyre Therapeutics Raises $350 Million as Short Sellers Bet $1.14 Billion Against Its Pipeline
Waltham, Sunday, 18 October 2026.
Biopharmaceutical firm Spyre Therapeutics (NASDAQ: SYRE) recently completed a $350 million follow-on equity offering to fund its long-acting antibody therapies for inflammatory bowel disease. Despite an impressive year-to-date share price surge of over 160%, market sentiment remains fiercely divided in October 2026. Most intriguingly, short sellers have accumulated a massive $1.14 billion position against the company—pushing short interest to 17.33% of its public float—setting the stage for significant volatility and a potential short squeeze. While recent insider sales totaling nearly $16.9 million reflect internal caution, prominent financial analysts reiterate a bullish long-term outlook on the firm’s advanced combination therapies. Backed by a refreshed capital balance and ongoing mid-stage trials targeting ulcerative colitis, Spyre stands at a high-stakes crossroads between heavy market skepticism and drug development potential.